Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Mon, 11.10.2021
Cardiol Therapeutics
Upcoming Investor Event:
Cardiol Therapeutics to present at digital International Investment Forum
(IIF)
On October 14, the IIF International Investment Forum will take place. At
this fo-rum, Cardiol Therapeutics will also present its business model and
current business development.
Presentation slot:
Cardiol Therapeutics Inc.
09.00 am EDT*
[ … ]
Mon, 04.10.2021
Coreo AG
1H 2021: earnings improvement due to higher rental income and sale of
properties; slight increase in 2021 forecasts; price target and rating
confirmed
As we expected, Coreo AG increased rental income to EUR1.93 million in the
first six months of 2021 (previous year: EUR1.55 million). The increase in
rental income is primarily attributable to the [ … ]
Mon, 27.09.2021
UmweltBank AG
H1 2021: Business volume significantly increased, forecasts and target
price slightly raised, rating reduced to HOLD after strong share price
performance
The increase in business volume, i.e. total assets plus contingent
liabilities and other obligations, forecast by the Umweltbank management
was impressively confirmed with the presentation of t [ … ]
Mon, 20.09.2021
wallstreet:online AG
HY1 2021: Continuation of dynamic customer and revenue growth; Significant
profitability increase expected in HY2; GBC estimates and price target
confirmed
Sales development HY1 2021
wallstreet:online AG (wallstreet:online) was able to continue its dynamic
growth course in the first six months of the current financial year.
Compared to the sam [ … ]
Mon, 13.09.2021
Cardiol Therapeutics Inc.
Die FDA hat die Freigabe zur Durchführung der klinischen Phase-II-Studie
für CardiolRX(TM) bei akute Myokarditis erteilt.
Dr. Guillermo Torre-Amione wurde zum neuen Vorsitzenden ernannt
Die Aktien der Cardiol Therapeutics sind nun auch an der NASDAQ gelistet.
Am 24. August erhielt Cardiol Therapeutics von der FDA die Freigabe des
IND-A [ … ]
Thu, 09.09.2021
Cardiol Therapeutics
On August 24th, Cardiol Therapeutics received FDA Clearance of
Investigational New Drug (IND) Application for Phase II Clinical Trial of
CardiolRx(TM) for Acute Myocarditis.
Phase II trial details
The company's Investigational New Drug (IND) application approval allows
Cardiol Therapeutics to commence a Phase II, multi-center, double-blind,
ra [ … ]
Tue, 31.08.2021
Media and Games Invest SE
Continuation of dynamic sales growth in H1 2021; Significant increase in
profitability due to economies of scale and M&A effects; GBC estimates and
target price also raised following increase in company guidance
Business development in HY1 2021
Media and Games Invest SE (MGI) was able to continue its dynamic growth
course in the first six [ … ]
Mon, 23.08.2021
Coreo AG
- Acceleration of investment activities
- Largest portfolio in the company's history acquired
- Further investments expected
Coreo AG has made extensive new acquisitions in the current financial year
2021. While the past financial year 2020 was still characterised by the
pandemic-related restrictions and thus only a low investment volume of EUR
[ … ]
Fri, 13.08.2021
Cardiol Therapeutics
Cardiol Therapeutics successful NASDAQ listing
NASDAQ Capital Market LLC has granted Cardiol final approval to list its
common shares on NASDAQ. On August 10, 2021, the Company's shares started
trading under the ticker 'CRDL'.
David Elsley, President & CEO of Cardiol Therapeutics, said, 'Listing on
NASDAQ is a major milestone for our Compa [ … ]
Fri, 13.08.2021
Aspermont Limited
- A rising star in the digital media service industry
- Profitable & scalable XaaS model
- Uninterrupted growth for the past 5 years
Aspermont Limited is the global leader in business-to-business (B2B) media
for the resources sector. The company publishes subscription-based content
services for the mining, energy, agriculture, and technology [ … ]
